| Novartis receives FDA approval of Tekamlo(TM), a single-pill combination of ... - MarketWatch (press release) |
|
|
MarketWatch (press release)Clinical trials with Tekamlo in hypertension excluded patients with severe renal impairment. Clinical trials of aliskiren in hypertension excluded patients ... read more |